Business development thrust with new Associates
Richard Archer, founder and former CEO of The Automation Partnership (TAP), will be instrumental in helping build our profile in the life sciences market. He has helped many of the world’s top pharmaceutical companies to achieve new levels of operating efficiency by automating their R&D and manufacturing processes, and he pioneered an industrialised ‘drug discovery factory’ approach in the search for potential new medicines.
In addition to his new role at 42 Technology, Richard is involved in advising a number of medical technology and related companies including: executive chairman of Axordia; chairman of tissue engineering company MagneCell, and a non-executive director at Gentronix. He is also a Senior Industrial Fellow at the Institute of Manufacturing, Cambridge University and on the board of Loughborough University’s Innovative Manufacturing Research Centre.
Adrian Swinburne will further strengthen our senior-level team and new business prospecting activities. Adrian, who was Chief Executive at Sagentia UK. (Scientific Generics) from August 1999 to February 2007, is helping us to identify and develop major new leads and partnership opportunities in consumer, industrial and utilities markets. Before his eight year career at Sagentia, Adrian held senior-level engineering management positions with international companies including MDSI, Watkins-Johnson and Racal (now Thales).